结肠肝曲癌侵犯门静脉行联合肠系膜上静脉-门静脉切除对端吻合重建手术

目的 探讨结肠肝曲癌侵犯门静脉行右半结肠根治切除(right hemicolectomy,RH)联合肠系膜上静脉-门静脉切除的胰十二指肠切除术(pancreaticoduodenectomy,PD)血管端端吻合的可行性.方法 总结2004-2011年吉林大学普通外科疾病诊疗中心、吉林大学第二医院普通外科行右半结肠根治切除术及胰十二指肠切除、联合肠系膜上-门静脉切除术后血管进行端端吻合5例患者的临床资料.结果 5例患者手术过程均顺利,肿瘤完全切除,无严重术后并发症及围手术期死亡,5例患者均康复出院.结论 结肠肝曲癌极易侵犯胰头十二指肠及(或)门静脉,行右半结肠癌根治切除术及胰十二指肠切除,联合肠系膜上-门静脉切除后均未间置人工血管进行端端吻合是一项安全可行的技术.     

机器人手术系统辅助结肠癌手术13例

目的探讨达芬奇机器人手术系统辅助结肠癌手术的安全性与可行性。方法回顾性总结2010年5-11月实施的13例达芬奇机器人手术系统辅助结肠癌手术的治疗效果。结果13例结肠癌患者行右半结肠切除5例、左半结肠切除3例、乙状结肠切除5例。手术均顺利完成,无中转开腹。手术时间（171．5±31．8）min,术中失血量（54．6±21．8）ml,术后肠蠕动恢复时间为（60．9±15．8）h,术后住院时间（6．4±3．6）d。术后除1例切口脂肪液化外,未出现出血、吻合口瘘、吻合口狭窄等并发症。结论达芬奇机器人手术系统应用于结肠癌手术安全可行。     

完全腹腔镜解剖性右半肝切除四例

目的 探讨腹腔镜下右半肝切除的方法 和临床效果.方法 于完全腹腔镜下解剖、阻断相应肝段、肝叶的入出肝血流,按解剖学标志切除右半肝共4例,其中3例右肝血管瘤、1例外伤性肝破裂.结果 4例患者均成功地在腹腔镜下施行了右肝切除术,无中转开腹,手术时间(470±42.7)min,术中出血量(1950±881.3)ml,术后住院(15±2.9)d,未发现并发症.结论 对于经过临床选择的病例,完全腹腔镜右半肝切除是安全可靠的微创方法,对肝脏良性疾病完全腹腔镜下病灶切除更具微创意义.

Abstract：

Objective To explore the method and clinical effect of laparoscopic anatomical right liver resections. Method The candidates for laparoscopic right hepatic lobectomys were 4 cases including 3 cases of liver hemangioma and 1 case of hepatorrhexis. Results The laparoscopic right hepatic lobectomy we performed saccess bully in all the 4 patients, operation time was (470±42.7)min. The blood loss in operation was ( 1950± 881.3) ml. The postoperative hospital stay was ( 15 ± 2.9) days.There was not complcation. Conclusions Laparoscopic right hepatic libectomy is feasible and safe.For the patients with benign liver disease, it is an operation with less operation wound.     

腹腔镜中间入路扩大右半结肠癌D3根治术

Lapareseopic colectomy is commonly performed,but laparoscopic extended right hemicolectomy with D3 lymphadenectomy for cancer located at hepatic flexure of the colon is a complex procedure,even in the ...     

基于da Vinci Xi?手术机器人的右半结肠切除术进展

新一代的da Vinci Xi^?手术机器人在可操作范围、对接流程、操作流畅度及可视化等方面均做出了优化，使其尤为适用于多象限的手术，在右半结肠切除术的应用中有望得到更多的获益。本文着重讨论da Vinci Xi^?手术系统相较于前代机器人在技术特点方面的改进，并回顾相关文献，简述基于该系统的右半结肠切除术在Trocar孔配置、手术入路上的进展，对其安全性、可行性做出讨论；与传统腹腔镜手术相比，在术中操作、术后恢复等相关临床数据的变化，分析da Vinci Xi^?手术机器人在右半结肠切除术中的临床获益。     

腹腔镜右半结肠切除中间入路与侧方入路的前瞻性随机对照研究

Objective To compare the medial-to-lateral approach with the lateral-to-medial approach in laparoscopic right hemi-colectomy for right colon cancer. Methods A prospective randomized controlled trial was performed in the Fujian provincial tumor hospital between January 2007 and July 2009. Forty-eight cases with right eolon cancer were randomly divided into two groups:medial-to- lateral laparoscopic right hemi-colectomy group(group M) and lateral-to-medial laparoscopic right hemicolectomy group(group L). Primary outcome(operative time) and secondary outcomes (estimated blood loss, intra-operative complication, post-operative complication, number of lymph node retrieval, hospital stay) were compared between two groups. Results Operative time was (122.5±25.8) min in group M and (162.9±30.9) min in Group L (P=0.01). Estimated blood loss was(55.8±36.2) ml in group M and (104.6±58.2) ml in group L (P=0.01). There were no significant differences between the two groups in intra-operative complications(4.2% vs 8.3%, P=1.00), post-operative complications (8.3% vs 16.7%,P=0.66), number of lymph node retrieval (17.4±3.2 vs 17.8±3.4, P=0.67), and hospital stay [(7.8± 2.2) d vs (8.0±3.6)d, P=0.81]. Conclusion The medial-to-lateral approach reduces operative time and blood loss in laparoscopic right hemi-colectomy as compared with the lateral-to-medial approach.     

腹腔镜右半结肠切除中间入路与侧方入路的前瞻性随机对照研究

Objective To compare the medial-to-lateral approach with the lateral-to-medial approach in laparoscopic right hemi-colectomy for right colon cancer. Methods A prospective randomized controlled trial was performed in the Fujian provincial tumor hospital between January 2007 and July 2009. Forty-eight cases with right eolon cancer were randomly divided into two groups:medial-to- lateral laparoscopic right hemi-colectomy group(group M) and lateral-to-medial laparoscopic right hemicolectomy group(group L). Primary outcome(operative time) and secondary outcomes (estimated blood loss, intra-operative complication, post-operative complication, number of lymph node retrieval, hospital stay) were compared between two groups. Results Operative time was (122.5±25.8) min in group M and (162.9±30.9) min in Group L (P=0.01). Estimated blood loss was(55.8±36.2) ml in group M and (104.6±58.2) ml in group L (P=0.01). There were no significant differences between the two groups in intra-operative complications(4.2% vs 8.3%, P=1.00), post-operative complications (8.3% vs 16.7%,P=0.66), number of lymph node retrieval (17.4±3.2 vs 17.8±3.4, P=0.67), and hospital stay [(7.8± 2.2) d vs (8.0±3.6)d, P=0.81]. Conclusion The medial-to-lateral approach reduces operative time and blood loss in laparoscopic right hemi-colectomy as compared with the lateral-to-medial approach.     

腹腔镜辅助右半结肠切除术 35例临床分析

目的探讨腹腔镜外科技术在右半结肠切除手术中的应用。方法对1999年8月至2003年8月施行腹腔镜辅助右半结肠切除术的35例患者的临床资料和随访情况进行回顾性分析。结果33例在腹腔镜下完成右半结肠分离,辅助小切口,于腹腔外行肠系膜上动静脉周围淋巴清扫、右半结肠切除和吻合。无手术死亡,中转开腹2例,中转率5.7%(2/35)。平均手术时间181min,平均出血量94ml,辅助切口平均长5cm,平均术后住院日9d,术后早期肠梗阻1例。33例患者术后随访1～48个月,1例DukesC2期中分化腺癌患者,术后4个月发现双肺及左锁骨上淋巴结转移。全组患者的Trocar穿刺孔及腹壁切口无肿瘤种植转移。结论腹腔镜辅助右半结肠切除术是安全可行的,适合于各期的回盲部和升结肠肿瘤。只要手术医师遵守肿瘤处理原则、熟练掌握腹腔镜技术,就能顺利地完成此类手术。     

机器人辅助腹腔镜下肾上腺复杂肿瘤手术(附光盘)

目前,传统腹腔镜肾上腺切除术(laparoscopic adrenalectomy,LA)已成为治疗大部分肾上腺肿瘤的首选方法,但其在处理一些复杂性肾上腺肿瘤时仍较困难。达芬奇机器人手术系统在泌尿外科领域的广泛应用和发展是当今世界临床医学发展的里程碑。机器人辅助腹腔镜下肾上腺切除术(robot-assisted laparoscopic adrenalectomy,RALA)使得一些不适合传统腹腔镜手术的肾上腺肿瘤的微创治疗成为可能。本文就达芬奇机器人手术系统、RALA用于复杂肾上腺肿瘤治疗、RALA的手术步骤和技巧做一概述。     

腹腔镜手助与辅助技术在右半结肠切除术中应用的对比研究

目的 比较腹腔镜手助与辅助技术在右半结肠癌根治术中的应用效果.方法 回顾性分析北京协和医院基本外科同一组医师2002年3月至2006年11月采用腹腔镜手助技术(HALS组,47例)和2007年1月至2009年12月采用腹腔镜辅助技术(LAS组,48例)完成的右半结肠癌根治术患者的临床资料.对比其手术安全性、术后恢复情况和并发症、肿瘤根治性、医疗费用和随访结果.结果 HALS组和LAS组术中、术后均无严重并发症和死亡病例.HALS组与LAS组相比,术中出血(P<0.01)、手术时间(P<0.05)和切口长度(P<0.05)差异均有统计学意义;但中转开腹、术中副损伤术后肛门排气时间、下床时间、住院天数、进食时间、术后镇痛例数方面的差异均无统计学意义(均P>0.05).HALS组手术切除标本长度为(25.6±9.9)cm,与LAS组的(26.8±7.9)cm比较,差异无统计学意义(P>0.05):HALS组淋巴结清扫总数为(18.2±12.1)枚,与LAS组的(24.1±9.3)枚比较,差异有统计学意义(P<0.05).LAS组的医疗费用(28 049.8±7576.1)元,多于HAKS组的(21 132.7±5323.4)元(P<0.05).HALS组和LAS组3年生存率分别为91.3%和87.9%,差异无统计学意义(P=0.452).结论 腹腔镜手助和辅助技术在右半结肠切除术中可获得相同的微创效果和肿瘤学疗效.

Abstract：

Objective To compare the outcomes of right hemicolectomy performed either by the hand-assisted laparoscopic (HALS) or conventional laparoscopic surgery (LAS). Methods Ninety-five patients undergoing HALS(n=47) from March 2002 to November 2006 or by LAS (n=48) from January 2007 to December 2009 were retrospectively studied. All the operations were performed by the same surgical team. Patient safety, postoperative recovery, complications, oncologic outcomes, medical expenses, and the follow-up results were compared between the two groups. Results No severe complications or perioperative deaths were oberved. There were significant differences between the two groups in terms of intraoperative bleeding, operative time, and length of incision (all P<0.05). However, the conversion rate, intraoperative injuries, time to first bowel movement, postoperative bedrest time, hospital stay, time to first oral intake, and the number of patients requiring postoperative analgesia were comparable between the two groups (P>0.05). Length of surgical specimen was (25.6±9.9) cm in the HALS group and was (26.8±7.9) cm in the LAS group, the diffenence was not statistically significant (P<0.05).The mean number of lymph nodes retrieved in HALS group was 18.2± 12.1, which was significantly lower than that in LAS group (24.1 ±9.3, P<0.05). The medical expense of the LAS group was (28 049.8±7576.1) RMB, which was significantly higher than that of the HALS group (21 132.7±5323.4) RMB (P<0.05). A follow-up rate of 93.7% was achieved in the HALS group with 3 patients lost to follow-up. The follow-up duration ranged from 45.4 to 101.9 months with a median of 66.7 months. In LAS group, the follow-up rate was 96% with 2 patients lost to follow-up and the follow-up duration ranged from 12.4 to 45.7 months with a median of 21.6 months. There was no significant difference in 3-year disease-free survival (91.3% vs. 87.9%, P> 0.05) between the two groups. Conclusion HALS and LAS can achieve similar minimal invasiveness efficacy and oncologic outcomes for right hemicolectomy.     

达芬奇机器人系统辅助左半结肠切除术

目的:探讨达芬奇辅助左半结肠切除术的安全性及可行性.方法:总结2010年5月至11月完成的3例达芬奇辅助左半结肠切除术的方法及术后恢复情况.结果:3例手术均顺利完成,无中转开腹.手术时间150～190min,术中出血量50～80ml.术后无并发症发生.结论:达芬奇系统用于左半结肠癌手术是安全可行的.     

腹腔镜右半结肠癌根治术中间入路与混合入路的近期疗效对比

目的:探讨腹腔镜中间入路与混合入路治疗右半结肠癌的近期疗效.方法:回顾分析2016年1月至2021年8月为109例患者行腹腔镜右半结肠癌根治术的临床资料,比较两组近期疗效.结果:混合入路组手术时间、术中出血量、术后首次排便时间均少于中间入路组,差异有统计学意义(P<0.05);两组术中淋巴结清扫数量、并发症发生率及其他...     

达芬奇辅助结肠次全切除术治疗结肠克罗恩病(附1例报告)

目的:探讨达芬奇辅助结肠次全切除术治疗结肠克罗恩病的安全性与可行性.方法:2010年9月为1例结肠克罗恩病患者施行了达芬奇辅助结肠次全切除术,研究其手术技术、手术安全性及患者术后恢复情况.结果:手术顺利完成,无术中并发症发生.术后第2天恢复胃肠道功能,第3天恢复肠内营养,第6天转至康复病房.结论:达芬奇系统用于结肠次全...     

Laparoscopic right hemicolectomy with intracorporeal anastomosis. Technical aspects and personal experience

BACKGROUND: Laparoscopic colo-rectal surgery has gained wide acceptance as a treatment in a variety of benign and malignant diseases. The reproducibility and safety of all the principal colo-rectal procedures has been demonstrated, but some indications are still controversial. A great part of surgeons perform right hemicolectomy by laparo-assisted technique and consider it more difficult than left hemicolectomy. METHODS: A retrospective analysis of a series of 180 laparoscopic colon resections performed between 1994 and 2001 is presented. Surgical indications were: 46 cases of benign disorders and 134 colonic malignancy. The right hemicolectomy were 27 (15%): 2 benign and 25 malignant diseases. The technical aspects of completely laparoscopic right hemicolectomy is described in details. A completely mechanical intra-corporeal anastomosis is always performed. To remove the bowel specimen from the abdominal cavity it is put it in a large bag and pull it out of a 3-4 cm enlargement of a trocar-site (in the umbilical scar). RESULTS: Data of the 27 laparoscopic right hemicolectomy were analysed: there was 1 conversion to open surgery; no intra-operative complications were observed; the postoperative period was complicated by 1 anastomotic fistula. The median operative time was of 150 minutes. No case of port-site recurrence was observed. CONCLUSIONS: The laparoscopic colo-rectal surgery can reproduce in selected patients, the techniques performed in open surgery with minimally invasive treatment. It is possible to perform a completely laparoscopic right hemicolectomy after an adequate training in advanced laparoscopy, anyway there are many advantages: less postoperative pain, short-term postoperative ileus, earlier return to daily activity.     

县级医院复制基于膜解剖的腹腔镜右半结肠癌根治术的初步经验 (附28例报告)

目的:探讨县级医院复制基于膜解剖右半结肠癌根治性切除术的可行性及应用价值.方法:回顾分析28例腹腔镜右半结肠癌手术(基于膜解剖术式)患者的临床资料,记录手术时间、术中出血量、清扫淋巴结数量、术后并发症、术后恢复情况.结果:28例手术均获成功,手术时间135～246 min,平均(182.2±41.3)min;术中出血量...     

腹腔镜右半结肠癌根治术177例临床分析

目的:探讨腹腔镜下右半结肠癌根治术的安全性及远期疗效。方法:回顾分析2002年2月至2009年3月间177例行腹腔镜下右半结肠癌D3根治术病人的临床资料,研究其手术安全性及近远期疗效。结果:本研究病人的平均手术时间(132.6±35.7)min,术中出血(94.2±34.1)mL,术后肠道排气时间、恢复流质饮食时间、术后住院天数分别为(2.13±0.74)d、(3.21±0.45)d、(10.35±2.72)d;平均切除标本长度(17.32±8.26)cm,淋巴结清扫数目(15±8)枚。中转开腹5例(2.82%),腹腔镜手助切除4例(2.26%)。并发症24例(13.56%)。术后随访39(12～97)个月,随访期内发现1例戳创孔肿瘤种植,局部复发5例(2.82%),远处转移7例(其中肺转移2例,肝转移4例,骨转移1例)。累计生存率、无病生存率及肿瘤相关生存率分别为83.69%、80.43%及83.14%。Dukes A期、B期、C期的5年生存率分别为93.23%、76.47%、66.67%。结论:腹腔镜右半结肠癌根治术是安全且符合肿瘤根治原则的,并能获得令人满意的近、远期疗效。     

Colectomie droite pour cancer

Right hemicolectomy is the surgical curative procedure for caecal or right colonic cancer. It can be performed through an open or laparoscopic approach, but implies some carcinological rules. Mortality and morbidity are low with an anastomotic leakage rate below 4%.     

Completely staple-free hand-sewn laparoscopic anastomosis in colorectal surgery

Colonic continuity following a laparoscopic left hemicolectomy is usually performed by using a circular stapler to achieve end-to-end colorectal anastomosis. However, not much consideration is given to the costs of this technique and the long-term risk of stenosis. In this paper, we report the first case of a completely staple-free hand-sewn laparoscopic colonic anastomosis (CSHLCA) following a laparoscopic left hemicolectomy for cancer. Total operative time was 170 minutes, and the time to perform the anastomosis was 38 minutes. The postoperative stay was uneventful, with a total hospital stay of 6 days. CSHLCA is feasible and can lower the cost of the laparoscopic procedure. It may be considered in countries with limited access to mechanical staplers.     

腹腔镜右半结肠癌切除术后消化道重建的研究现状及前景

腹腔镜右半结肠癌切除术后腹腔内吻合正逐渐成为结直肠手术领域中的热点。研究者发现:腹腔内吻合与腹腔外吻合比较,前者在促进病人术后恢复,降低术后并发症发生率等方面有潜在优势。且腹腔内吻合较腹腔外吻合病人术后胃肠功能恢复更快、术后疼痛评分更低。但对于腹腔内吻合的并发症发生率,尤其是重要指标吻合口漏的比较,尚缺乏足够证据。而手术技术不统一、吻合口漏定义不明确是目前研究的主要困难。多项高质量的前瞻性随机对照试验目前正在进行中,对于腹腔镜右半结肠癌切除术的客观评价仍需要更高级别的循证医学证据验证。笔者综合分析国内外研究进展,系统阐述腹腔镜右半结肠癌切除术后消化道重建的研究现状及前景,旨在为我国结直肠外科临床研究探索新方向。     

腹腔镜右半结肠切除尾侧入路与中间入路的临床随机对照研究

背景与目的:腹腔镜结肠切除术已被广泛用于结肠癌根治术中,选择合适的手术入路对手术疗效起重要作用。由于右半结肠区域血管走行复杂,因此右半结肠切除术的操作难度更高,需要慎重选取手术入路。本研究通过比较右半结肠切除术中尾侧入路与中间入路的临床效果,探讨该手术的最佳手术入路。方法:选取2016年5月-2019年5月收治并确诊为右半结肠癌的患者136例,随机分为两组,每组各68例。一组患者采用尾侧入路行腹腔镜右半结肠切除术(尾侧入路组),另一组患者采用中间入路行腹腔镜右半结肠切除术(中间入路组)。比较两组患者的相关临床指标以及术后生存情况。结果:两组患者术前基线资料差异无统计学意义(均P>0.05)。尾侧入路组患者平均手术时间(123.52 min vs.168.64 min)、平均术中出血量(12.46 mL vs.24.28 mL)、中转开腹率(2.94%vs.11.76%)均明显优于中间入路组(均P<0.05)。两组患者的通气时间、通便时间、恢复饮食时间、引流量、引流时间、住院时间差异均无统计学意义(均P>0.05);尾侧入路组患者的切口感染、肺部炎症、吻合口瘘、及肠梗阻发生率及总并发症发生率(23.53%vs.35.29%)均明显低于中间入路组(均P<0.05);两组患者术后淋巴结清扫数、TNM分期差异无统计学意义(均P>0.05)。尾侧入路组患者术后2年生存率明显高于中间入路组(82.35%vs.52.94%,P<0.05)。结论:尾侧入路腹腔镜右半结肠切除术具有安全、微创、简便、可操作性好的优势,有利于保证手术视野的充分及解剖定位的准确,其近远期疗效均优于中间入路腹腔镜右半结肠切除术。